Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Li, Jia-Yi, Englund, Elisabet, Holton, Janice L, Soulet, Denis, Hagell, Peter, Lees, Andrew J, Lashley, Tammaryn, Quinn, Niall P +6 more·2008·Nature Medicine

DOI 10.1038/nm1746

Cited by (1,002)

Items 701–800 of 1,002

Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson’s Disease
Young Cha, Tae-Yoon Park, Pierre R Leblanc, Kwang‐Soo Kim · 2023 · Journal of Movement Disorders
Prevalence of Concomitant Pathologies in Parkinson’s Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms
Lauren Walker, Johannes Attems · 2023 · Journal of Parkinson s Disease
New perspectives on the glymphatic system and the relationship between glymphatic system and neurodegenerative diseases
Yan-rui Sun, Qian-Kun Lv, Junyi Liu, Fen Wang, Chun‐Feng Liu · 2025 · Neurobiology of Disease
Pathologic findings in retinal pigment epithelial cell implantation for Parkinson disease
Emad S. Farag, Harry V. Vinters, Jeff M. Bronstein · 2009 · Neurology
Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice
Franz Marxreiter, Benjamin Ettle, Verena Elisabeth Luise May, Hakan Esmer, Christina Patrick, Christine Lund Kragh, Jochen Klucken, Beate Winner, Olaf Rieß, Jürgen Winkler et al. · 2013 · Neurobiology of Disease
The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation
Diana F. Lázaro, Mariana Castro Dias, Anita Čarija, Susanna Navarro, Carolina Silva Madaleno, Sandra Tenreiro, Salvador Ventura, Tiago F. Outeiro · 2016 · Acta Neuropathologica Communications
Specification of Physiologic and Disease States by Distinct Proteins and Protein Conformations
Daniel F. Jarosz, Vikram Khurana · 2017 · Cell
What Is the Evidence that Parkinson’s Disease Is a Prion Disorder, Which Originates in the Gut?
Małgorzata Kujawska, Jadwiga Jodynis‐Liebert · 2018 · International Journal of Molecular Sciences
Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease
Michael X. Henderson, Dustin J. Covell, Charlotte Hiu-Yan Chung, Rose M. Pitkin, Raizel M. Frasier, Samantha C. Decker, Dawn M. Riddle, Bin Zhang, Ronald J. Gathagan, Michael J. James et al. · 2019 · Neurobiology of Disease
Manganese Upregulates Cellular Prion Protein and Contributes to Altered Stabilization and Proteolysis: Relevance to Role of Metals in Pathogenesis of Prion Disease
Christopher J. Choi, Vellareddy Anantharam, Dustin Paul Martin, Eric M. Nicholson, Jürgen A. Richt, Arthi Kanthasamy, Anumantha G. Kanthasamy · 2010 · Toxicological Sciences
Prion-like propagation of cytosolic protein aggregates
Carmen I. Nussbaum-Krammer, Hermann M. Schätzl, Ina Maja Vorberg · 2009 · Prion
α-Synuclein mutations cluster around a putative protein loop
Eleanna Kara, Patrick Alfryn Lewis, Helen Ling, Christos Proukakis, Henry Houlden, John Hardy · 2013 · Neuroscience Letters
Stem cell transplantation therapy in Parkinson’s disease
Mu‐Hui Fu, Chia-Ling Li, Hsiu-Lien Herbie Lin, Pei‐Chun Chen, Marcus J. Calkins, Yu-Fan Chang, Pei‐Hsun Cheng, Shang‐Hsun Yang · 2015 · SpringerPlus
Alpha-synuclein and the prion hypothesis in Parkinson's disease
Ronald Melki · 2018 · Revue Neurologique
Autonomic dysfunction in Parkinson disease and animal models
Jeanette M. Metzger, Marina Elena Emborg · 2019 · Clinical Autonomic Research
Spreading of alpha‐synuclein – relevant or epiphenomenon?
Bryan A. Killinger, Jeffrey H. Kordower · 2019 · Journal of Neurochemistry
Neuroprotection in Parkinson's disease
Anthony H.V. Schapira · 2009 · Parkinsonism & Related Disorders
α-Synuclein in Parkinson's Disease: Pathogenic Function and Translation into Animal Models
Judith Eschbach, Karin M. Danzer · 2013 · Neurodegenerative Diseases
Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo
Katrina Albert, Diana Pelizzari Raymundo, Anne E. Panhelainen, Ave Eesmaa, Liana Shvachiy, Gabriela Rocha de Araújo, Piotr Chmielarz, Yan Xu, Aastha Singh, Yraima Cordeiro et al. · 2021 · Molecular Therapy
α-Synuclein: A therapeutic target for Parkinson’s disease?
Kathleen A. Maguire‐Zeiss · 2008 · Pharmacological Research
Genetic variability in SNCA and Parkinson’s disease
Lasse Pihlstrøm, Mathias Toft · 2011 · Neurogenetics
Intracerebral Transplantation of Differentiated Human Embryonic Stem Cells to Hemiparkinsonian Monkeys
Marina Elena Emborg, Zhijian Zhang, Valerie L. Joers, Kevin G. Brunner, Viktorya Bondarenko, Sachiko Ohshima, Su‐Chun Zhang · 2013 · Cell Transplantation
Human mesenchymal stem cells in the treatment of neurological diseases
Katarzyna Drela, Patrycja Siedlecka, Anna Sarnowska, Krystyna Domańska‐Janik · 2013 · Acta Neurobiologiae Experimentalis
RETRACTED: α ‐synuclein conformational antibodies fused to penetratin are effective in models of Lewy body disease
Brian J. Spencer, Stephanie M. Williams, Edward M. Rockenstein, Elvira Valera, Wei Xin, Michael Mante, Jazmin B. Florio, Anthony Adame, Eliezer Masliah, Michael R. Sierks · 2016 · Annals of Clinical and Translational Neurology · Retracted
Novel animal model defines genetic contributions for neuron-to-neuron transfer of α-synuclein
Trevor Tyson, Megan M. Senchuk, Jason F. Cooper, Sonia George, Jeremy M. Van Raamsdonk, Patrik Brundin · 2017 · Scientific Reports
Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid
Keita Kakuda, Kensuke Ikenaka, Katsuya Araki, Masatomo So, César Aguirre, Yuta Kajiyama, Kuni Konaka, Kentaro Noi, Kousuke Baba, Hiroshi Tsuda et al. · 2019 · Scientific Reports
Insights of Extracellular Vesicles of Mesenchymal Stem Cells: a Prospective Cell-Free Regenerative Medicine for Neurodegenerative Disorders
Pankhi Vatsa, Renu Negi, Uzair Ahmad Ansari, VK Khanna, Aditya Bhushan Pant · 2021 · Molecular Neurobiology
Lewy body pathology in long-term fetal nigral transplants: is parkinson's disease transmitted from one neural system to another?
Jeffrey H. Kordower, Patrik Brundin · 2008 · Neuropsychopharmacology
MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse Brain
Jie Zhang, Mengyuan Zhao, Run Yan, Jun Liu, Santhosh Chandar Maddila, Eunsung Junn, M. Maral Mouradian · 2021 · Neurotherapeutics
α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies
Francisco Javier Padilla-Godínez, Eunice Ruth Vázquez-García, María Isabel Trujillo-Villagrán, Luis Oskar Soto-Rojas, Marcela Palomero‐Rivero, Omar Hernández-González, Francisco Pérez-Eugenio, Omar Collazo-Navarrete, Óscar Arias-Carrión, Magdalena Guerra‐Crespo · 2025 · Frontiers in Neuroscience
What can pluripotent stem cells teach us about neurodegenerative diseases?
Hynek Wichterle, Serge Przedborski · 2010 · Nature Neuroscience
Initiation and propagation of neurodegeneration
Christian Haass · 2010 · Nature Medicine
Cell-based therapies for Parkinson’s disease
Sean C. Dyson, R. Barker · 2011 · Expert Review of Neurotherapeutics
Parkinson's disease, proteins, and prions: Milestones
C. Warren Olanow, K. St. P. McNaught · 2011 · Movement Disorders
Phosphodiesterase 7 Inhibition Induces Dopaminergic Neurogenesis in Hemiparkinsonian Rats
Jose Angel Morales-Garcia, Sandra Alonso‐Gil, Carmen Gil, Ana Martı́nez, Ángel Santos, Ana Pérez‐Castillo · 2015 · Stem Cells Translational Medicine
Potential of Neural Stem Cell-Based Therapy for Parkinson’s Disease
Chung-Hsing Chou, Hueng‐Chuen Fan, Dueng‐Yuan Hueng · 2015 · Parkinson s Disease
α-Synuclein nonhuman primate models of Parkinson’s disease
David J. Marmion, Jeffrey H. Kordower · 2017 · Journal of Neural Transmission
A critical review of the prion hypothesis of human synucleinopathies
Gültekin Tamgüney, Amos D. Korczyn · 2017 · Cell and Tissue Research
The cellular and pathologic prion protein
Andrew C. Gill, Andrew R. Castle · 2018 · Handbook of clinical neurology
Cyclized NDGA modifies dynamic α-synuclein monomers preventing aggregation and toxicity
Malcolm J. Daniels, J. Brucker Nourse, Hanna Kim, Valerio Sainati, Marco Schiavina, Maria Grazia Murrali, Buyan Pan, John Joseph Ferrie, Conor M. Haney, Rani Moons et al. · 2019 · Scientific Reports
Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, Iekhsan Othman, Mohd. Farooq Shaikh · 2020 · Biology
Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease
M. C. Pereira, M. Secco, D. E. Suzuki, Luciana Janjoppi, C. Rodini, Layla B. Torres, B. Araujo, E. Cavalheiro, M. Zatz, O. Okamoto · 2011 · Stem Cell Reviews and Reports
Differentiating human stem cells into neurons and glial cells for neural repair
Vimal Selvaraj · 2011 · Frontiers in bioscience
Cryo-EM structure of alpha-synuclein fibrils amplified by PMCA from PD and MSA patient brains
Domenic Burger, Alexis Fenyi, Luc Bousset, Henning Stahlberg, Ronald Melki · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Astrocytes conspire with neurons during progression of neurological disease
James C. McGann, Daniel T. Lioy, Gail Mandel · 2012 · Current Opinion in Neurobiology
Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy Bodies
Rimona Sharon Weil, Tammaryn Lashley, José Brás, Anette E. Schrag, Jonathan M. Schott · 2017 · F1000Research
Pα-syn* mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria
Diego Grassi, Natalia Diaz-Perez, Laura A. Volpicelli‐Daley, Corinne Ida Lasmézas · 2018 · Neurobiology of Disease
Recapitulating Parkinson's disease pathology in a three-dimensional human neural cell culture model
Teresa Rachel Taylor-Whiteley, Christine Lyn Le Maitre, James A. Duce, Caroline Dalton, David P. Smith · 2019 · Disease Models & Mechanisms
Parkinson’s Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges
Watanabe, Hirohisa, Dijkstra, Johannes M., Nagatsu, Toshiharu · 2024 · International Journal of Molecular Sciences
Resident adult neural stem cells in Parkinson′s disease—The brain′s own repair system?
Simone A. van den Berge, Miriam E. van Strien, Elly M. Hol · 2013 · European Journal of Pharmacology
Adult Bone Marrow: Which Stem Cells for Cellular Therapy Protocols in Neurodegenerative Disorders?
Sabine Wislet‐Gendebien, Emerence Laudet, Virginie Neirinckx, Bernard Rogister · 2012 · BioMed Research International
Neurogenic potential of progenitor cells isolated from postmortem human Parkinsonian brains
Shanshan Wang, Michael S. Okun, Oleg N. Suslov, Tong Zheng, Nikolaus R. McFarland, Vinata Vedam‐Mai, Kelly D. Foote, Steven N. Roper, Anthony T. Yachnis, Florian A. Siebzehnrübl et al. · 2012 · Brain Research
Adult subventricular zone neural stem cells as a potential source of dopaminergic replacement neurons
John W. Cave, Meng Wang, Harriet Baker · 2014 · Frontiers in Neuroscience
Rebels with a cause: molecular features and physiological consequences of yeast prions
David M. Garcia, Daniel F. Jarosz · 2013 · FEMS Yeast Research
Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease
Emma L. Lane, Denis Soulet, Linda Vercammen, Maria Angela Cenci, Patrik Brundin · 2008 · Neurobiology of Disease
Alpha-Synuclein Expression in Patients with Parkinson's Disease: A Clinician's Perspective
Han‐Joon Kim · 2013 · Experimental Neurobiology
Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders
Negin Nouraei, Daniel M. Mason, Kristin M. Miner, Michael A. Carcella, Tarun N. Bhatia, Benjamin K. Dumm, Dishaben Soni, David A. Johnson, Kelvin C. Luk, Rehana K. Leak · 2017 · Experimental Neurology
Clinical potential and current progress of mesenchymal stem cells for Parkinson’s disease: a systematic review
Ying Chen, Jiabing Shen, Kaifu Ke, Xiaosu Gu · 2020 · Neurological Sciences
Analysis of α-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies
John Burdon Sanderson, Suman De, Haiyang Jiang, Matteo Rovere, Ming Jin, Ludovica Zaccagnini, Aurelia Hays Watson, Laura de Boni, Valentina N. Lagomarsino, Tracy L. Young‐Pearse et al. · 2020 · Brain Communications
Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology
Efthalia Angelopoulou, Yam Nath Paudel, Chiara Villa, Mohd. Farooq Shaikh, Christina Piperi · 2020 · Biology
Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
Stephanie Lohmann, Jéssica Grigoletto, María Eugenia Bernis, Verena Pesch, Liang Ma, Sara Reithofer, Gültekin Tamgüney · 2022 · Acta Neuropathologica Communications
Small but Mighty—Exosomes, Novel Intercellular Messengers in Neurodegeneration
Meena Kumari, Antje Anji · 2022 · Biology
Therapeutic Strategies for Immune Transformation in Parkinson’s Disease
Maamoon Saleh, Milica Marković, Katherine E. Olson, Howard Eliot Gendelman, Rodney Lee Mosley · 2022 · Journal of Parkinson s Disease
Protein aggregation in Parkinson’s disease
Vidar Gundersen · 2010 · Acta Neurologica Scandinavica
Reprogramming Therapeutics: iPS Cell Prospects for Neurodegenerative Disease
Asa Abeliovich, Claudia A. Doege · 2009 · Neuron
Do prions cause Parkinson disease?: The evidence accumulates
C. Warren Olanow · 2014 · Annals of Neurology
Transcellular propagation of fibrillar α-synuclein from enteroendocrine to neuronal cells requires cell-to-cell contact and is Rab35-dependent
Paulla Vieira Rodrigues, João Vitor Pereira de Godoy, Beatriz Pelegrini Bosque, Dionísio Pedro Amorim Neto, Katiane Tostes, Soledad Palameta, Sheila Garcia-Rosa, C.C.C. Tonoli, Hernandes F. Carvalho, Matheus de Castro Fonseca · 2022 · Scientific Reports
Biophysical groundwork as a hinge to unravel the biology of α-synuclein aggregation and toxicity
Nicoletta Plotegher, Elisa Greggio, Marco Bisaglia, Luigi Bubacco · 2014 · Quarterly Reviews of Biophysics
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?
Francesca Cicchetti, Roger A. Barker · 2014 · Frontiers in Pharmacology
Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?
Elisa Greggio, Marco Bisaglia, Laura Civiero, Luigi Bubacco · 2011 · Molecular Neurodegeneration
Studying Parkinson’s disease using Caenorhabditis elegans models in microfluidic devices
Khaled Youssef, Anurag Tandon, Pouya Rezai · 2019 · Integrative Biology
Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?
Philip C. Buttery, Roger A. Barker · 2020 · Neurotherapeutics
The prion-like phenomenon in Alzheimer’s disease: Evidence of pathology transmission in humans
Ruben Gomez‐Gutierrez, Rodrigo Morales · 2020 · PLoS Pathogens
Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight
Gianluigi Forloni, Pietro La Vitola, Milica Cerovic, Claudia Balducci · 2020 · Progress in molecular biology and translational science
Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia
Katrina Albert, Jonna Niskanen, Sara Kälvälä, Šárka Lehtonen · 2021 · International Journal of Molecular Sciences
Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson’s disease
Anna Tamburrino, Madeline J. Churchill, Oi Wan Wan, Yolanda Colino‐Sanguino, Rossana Ippolito, Sofie Bergstrand, Daniel A. Wolf, Niculin J. Herz, Michelle D. Sconce, Anders Björklund et al. · 2015 · Acta Neuropathologica Communications
Idiopathic Parkinson's disease patient‐derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains
Tetsuhiro Kikuchi, Asuka Morizane, Daisuke Doi, Keisuke Okita, Masato Nakagawa, Hodaka Yamakado, Haruhisa Inoue, Ryōsuke Takahashi, Jun B. Takahashi · 2017 · Journal of Neuroscience Research
Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells
Kai‐Yin Chau, J Allen D Cooper, Anthony H.V. Schapira · 2010 · Neurochemistry International
Current insights and assumptions on α-synuclein in Lewy body disease
Rehana K. Leak, Rachel N. Clark, Muslim Abbas, Fei Xu, Jeffrey L. Brodsky, Jun Chen, Xiaoming Hu, Kelvin C. Luk · 2024 · Acta Neuropathologica
Quality Control Compartments Coming of Age
Tziona Ben‐Gedalya, Ehud Cohen · 2012 · Traffic
Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies
Sarah K. Kaufman, Marc I. Diamond · 2013 · Neurotherapeutics
Functions of the nigrostriatal dopaminergic synapse and the use of neurotransplantation in Parkinson’s disease
Alex Tsui, Ole Isacson A · 2011 · Journal of Neurology
In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies
Amir Tayaranian Marvian, David J. Koss, Farhang Aliakbari, Dina Morshedi, Tiago F. Outeiro · 2019 · Journal of Neurochemistry
A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body–like pathology
Juan Gerez, Natalia Cecilia Prymaczok, Edward M. Rockenstein, U. Herrmann, Petra Schwarz, Anthony Adame, Radoslav Ivanov Enchev, Thibault Courthéoux, Paul J. Boersema, Roland Riek et al. · 2019 · Science Translational Medicine
α-Synuclein aggregation and transmission in Parkinson’s disease: a link to mitochondria and lysosome
Rui Wang, Hongyang Sun, Haigang Ren, Guanghui Wang · 2020 · Science China Life Sciences
Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease
De-Hai Gou, Ting‐Ting Huang, Wen Li, Xin-Di Gao, Caroline Haikal, Xin-He Wang, Dong‐Yan Song, Xin Liang, Lin Zhu, Yong Cheng Tang et al. · 2020 · Redox Biology
Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease
Mengyuan Guo, Xunming Ji, Jia Liu · 2022 · Frontiers in Aging Neuroscience
Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non‐human primate after overexpression of GDNF
D. Eugene Redmond, John D. Elsworth, R.H. Roth, Csaba Léránth, Timothy J. Collier, Barbara C. Blanchard, Kimberly B. Bjugstad, Richard Jude Samulski, Patrick Aebischer, John R. Sladek · 2009 · The Journal of Comparative Neurology
Transplantation of GABA-Producing Cells for Seizure Control in Models of Temporal Lobe Epilepsy
Kerry W. Thompson · 2009 · Neurotherapeutics
Evidence for Prion-Like Mechanisms in Several Neurodegenerative Diseases: Potential Implications for Immunotherapy
Kristen Marciniuk, Ryan Taschuk, Scott Napper · 2013 · Clinical and Developmental Immunology
The Transcellular Propagation and Intracellular Trafficking of α-Synuclein
George K. Tofaris, Michel Goedert, Maria Grazia Spillantini · 2016 · Cold Spring Harbor Perspectives in Medicine
Clinical trials of neural transplantation in Huntington's disease
Anne Rosser, Anne‐Catherine Bachoud‐Lévi · 2012 · Progress in brain research
Parkinson’s disease: an update on pathogenesis and treatment
Thomas Foltynie, Joshua Kahan · 2013 · Journal of Neurology
The Evidence for the Spread and Seeding Capacities of the Mutant Huntingtin Protein in in Vitro Systems and Their Therapeutic Implications
Maria Masnata, Francesca Cicchetti · 2017 · Frontiers in Neuroscience
Neurological effects of glucocerebrosidase gene mutations
Stephen Mullin, Derralynn A. Hughes, Atul B Mehta, Anthony H.V. Schapira · 2018 · European Journal of Neurology
α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?
Simon Oliver Hoppe, Gamze Uzunoğlu, Carmen I. Nussbaum-Krammer · 2021 · Biomolecules
Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection
Zsigmond Tamás Kincses, László Vécsei · 2010 · CNS Neuroscience & Therapeutics
Toxicity of extracellular secreted alpha-synuclein: Its role in nitrosative stress and neurodegeneration
Anna Wilkaniec, Joanna Benigna Strosznajder, Agata Adamczyk · 2013 · Neurochemistry International
Cell-Based Therapies for Parkinson's Disease: Past, Present, and Future
Kathleen M. Fitzpatrick, James Raschke, Marina Elena Emborg · 2009 · Antioxidants and Redox Signaling
α-Synuclein and nonhuman primate models of Parkinson's disease
Scott Vermilyea, Marina Elena Emborg · 2015 · Journal of Neuroscience Methods